QDEL

QuidelOrtho Corporation Common Stock

Basic Materials · In Vitro & In Vivo Diagnostic Substances
$11.55-7.00% today
AI Take · AlgoThesis

QuidelOrtho's 23.39% short interest is exceptionally elevated, creating structural squeeze potential if sentiment shifts, though the stock trades well below its 52-week high with an RSI of 37.8 suggesting room to recover from oversold conditions. The absence of a P/E ratio signals unprofitability, which explains the bearish positioning despite the modest $0.9B market cap. This combination—significant short exposure paired with negative earnings and depressed technicals—presents a high-risk, high-volatility setup where positive catalysts could trigger rapid covering, but fundamental concerns about the diagnostic company's path to profitability remain unresolved.

Snapshot

Market cap
$860.7M
P/E
Forward P/E
5.4
EPS (TTM)
$-16.66
Dividend yield
Net margin
-41.5%
ROE
-46.5%
RSI (14)
38
Beta
2.37
Short % of float
23.4%
Days to cover
5.7
52w high
No

Recent headlines

Peers in In Vitro & In Vivo Diagnostic Substances

Build a thesis around QDEL

Type a thesis in plain English. AlgoThesis researches it with real data, cites sources, and hands back a tradeable basket.

Open in AlgoThesis →